Turkey intestine as a commercial source of heparin? Comparative structural studies of intestinal avian and mammalian glycosaminoglycans

Comparative Biochemistry and Physiology - B Biochemistry and Molecular Biology

Volumn 134, Issue 1, 2003, Pages 189-197

  Warda, Mohamad ^a   Mao, Wenjun ^b   Toida, Toshihiko ^c   Linhardt, Robert J ^b  

^a Cairo University   (Egypt)

^b E11 SSH   (United States)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

Avian; Heparin; Heparin sulfate; Intestine; Mammalian

Indexed keywords

GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN;

ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANALYSIS; DRUG STRUCTURE; INTESTINE; NONHUMAN; PRIORITY JOURNAL; SWINE; TURKEY (BIRD);

ANIMALIA; AVES; MAMMALIA; SUIDAE;

EID: 0037228857     PISSN: 10964959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-4959(02)00250-6     Document Type: Article

References (39)

1. Al-Hakim A., Linhardt R.J. Electrophoresis and detection of nanogram quantities of exogenous and endogenous glycosaminoglycans in biological fluids. Appl. Theoret. Electrophoresis. 1:1991;305-312.
2. Archer R.K. Blood coagulation. Bell D.J., Freeman B.M. Physiology and biochemistry of domestic fowl. 2:1971;897-911 Academic Press, New York.
3. Bianchini P., Liverani L., Mascellani G., Parima B. Heterogeneity of unfractionated heparins studied in connection with species, source and production processes. Sem. Thromb. Hemost. 23:1997;3-10.
4. Bigland C.H., Triantaphyllopoulos D.C. A re-evaluationof clotting time of chicken blood. Nature. 186:1960;644.
5. Bigland C.H. Blood clotting times of five avian species. Poult. Sci. 43:1964;1035-1039.
6. Bitter T., Muir H.M. A modified uronic acid carbazole reaction. Anal. Biochem. 4:1962;330-334.
7. Didisheim P., Hattori K., Lewis J.H. Hematologic and coagulation studies in various animal species. J. Lab. Clin. Med. 53:1959;866-875.
8. Doerr J.A., Hamilton P.B. New evidence for intrinsic blood coagulation in chickens. Poult. Sci. 60:1981;237-242.
9. Edens R.E., Al-Hakim A., Weiler J.M., Rethwisch D.G., Fareed J., Linhardt R.J. Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives. J. Pharm. Sci. 81:1992;823-827.
10. Einnarsson R., Andersson L.O. Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence. Biochim. Biophys. Acta. 490:1977;104-111.
11. Grant A.C., Linhardt R.J., Fitzgerald G., Park J.J., Langer R. Metachromatic Activity of Heparin and Heparin Fragments. Anal. Biochem. 137:1984;25-32.
12. Griffin C.C., Linhardt R.J., Van Gorp C.L., Toida T., Hileman R.E., Schubert R.L., Brown S.E. Isolation and characterization of heparan sulfate from crude porcine intestinal mucosa peptidoglycan heparin. Carbohydr. Res. 276:1995;183-197.
13. Furukawa K., Terayama H. Isolation and identification of glycosaminoglycans associated with purified nuclei from rat liver. Biochim. Biophys. Acta. 499:1977;278-289.
14. Hovingh P., Piepkorn M., Linker A. Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulfates. Biochem. J. 237:1986;573-581.
15. Jordan R.E. Antithrombin in vertebrate species: conservation of the heparin-dependent anticoagulant mechanism. Arch. Bioch. Biophys. 227:1983;587-595.
16. Jordan R.E., Favreau L.V., Braswell E.H., Rosenberg R.D. Heparin with two binding sites for antithrombin or platelets factor 4. J. Biol. Chem. 257:1982;400-4006.
17. Jordan R.E., Oosta G.M., Gardner W.T., Rosenberg R.D. The binding of low-molecular-weight to hemostatic enzymes. J. Biol. Chem. 255:1980a;10073.
18. Jordan R.E., Oosta G.M., Gardner W.T., Rosenberg R.D. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular-weight heparin. J. Biol. Chem. 255:1980b;10081.
19. Koide T., Ohta Y., Odani S., Ono T. Chicken antithrombin. Isolation, characterization, and comparison with mammalian antithrombins and chicken ovalbumin. J. Biochem. 91:1982;1223-1229.
20. Kurachi K., Schmer G., Hermodson M.A., Teller D.C., Davie E.W. Biochemistry. 15:1976;368-373.
21. Linhardt R.J., Ampofo S.A., Fareed J., Hoppensteadt D., Mulliken J.B., Flokman J. Biochemistry. 31:1992;12441-12445.
22. Linhardt R.J., Gunay N.S. Production and chemical processing of low molecular weight heparins. Sem. Thromb. Hemost. 25:1999;5-16.
23. Loganathan D., Wang H.M., Malli L.M., Linhardt R.J. Structural variation in the antithrombin III binding site region and its occurance in heparin from different sources. Biochemistry. 29:1990;4362-4368.
24. Pervin A., Al-Hakim A., Linhardt R.J. Separation of glycosaminoglycan-derived oligosaccharide by capillary electrophoresis using reverse polarity. Anal. Biochem. 221:1994;182-188.
25. Pervin A., Gallo C., Jandik K.A., Han X., Linhardt R.J. Preparation and structural characterization of large heparin-derived oligosaccharides. Glycobiology. 5:1995;83-95.
26. Ratnoff O.D., Rosenblum M. Role of Hageman factor in the initiation of clotting by glass. Am. J. Med. 25:1958;160-168.
27. Regelson W. The antimitotic activity of polyanions (antitumor, antiviral and antibacterial action of heparin, heparinoids, anionic dyes, and synthetic polymers). Goldin A., Hawing F., Schmitzer R.J. Advances in Chemotherapy 3. 1968;303-307 Academic Press, NewYork.
28. Rosenberg R.D., Lam L.H. Correlation between structure and function of heparin. Proc. Natl. Acad. Sci. USA. 76:1979;1218-1222.
29. Schonberger L.B. New variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Infect. Dis. Clin. North Am. 12:1998;111-121.
30. Sørbye O. Studies on the coagulation of chicken blood. IX. Labile factor activity of fresh oxalated plasma: the combined activity of sixteen discrete labile coagulation factors. Acta Chem. Scand. 16:1962;2411-2420.
31. Stopforth A. A study of coagulation mechanisms in domestic chickens. J. Comp. Pathol. 80:1970;525-533.
32. Straus A.H., Nader H.B., Dietrich C.P. Absence of heparin or heparin-like compounds in mast-cell-free tissues and animals. Biochim. Biophy. Acta. 717:1982a;478-485.
33. Straus A.H., Nader H.B., Takahashi H.K., Dietrich C.P. Ontogeny of heparin in mammals: a correlation with the appearance of mast cells in tissues. Anais da Academia Brasileira de Ciencias. 54:1982b;439.
34. Toida T., Shima M., Azumaya S., Maruyama T., Toyoda H., Imanari T., Linhardt R.J. Detection of glycosaminoglycans as a copper (II) complex in HPLC. J. Chromat. 787:1997;266-270.
35. Teien A.N., Lie M., Abildgaard U. Assay of heparin in plasma using a chromogenic substrate. Throm. Res. 8:1976;413-416.
36. Teien A.N., Lie M. Evaluation of an amidolytic heparin assay method: increased sensitivity by adding purified antithrombin III. Throm. Res. 10:1977;399-410.
37. Vaheri A. Heparin and related polyionic substances as virus inhibitors. Acta Pathol. Microbiol. Scand. Suppl. 171:1964;7.
38. Van Gorp C.L. Clin. Hemost. Rev. 9:1995;17-18.
39. Weiss L. The thymus. The Blood Cells and Hematopoietic Tissues. 1977;503-507 McGraw Hill, USA.